Flecainide is an antiarrhythmic medication used to treat certain types of abnormal heart rhythms, specifically supraventricular arrhythmias [1].
How does flecainide work to control heart rhythm?
Flecainide functions by blocking certain ion channels in the heart muscle, primarily sodium channels [2]. By inhibiting these channels, it slows the conduction of electrical impulses through the atria and ventricles, which helps to stabilize the heart's rhythm [2]. This mechanism is key to its effectiveness in treating conditions like atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia, and ectopic atrial tachycardia [1].
What specific heart rhythm disorders does flecainide address?
The primary indications for flecainide include the prevention and treatment of paroxysmal supraventricular tachycardias (PSVT), such as those caused by Wolff-Parkinson-White syndrome [3]. It is also used to maintain normal sinus rhythm in patients with atrial fibrillation or atrial flutter [3]. Additionally, flecainide can be prescribed for symptomatic ventricular arrhythmias that are considered life-threatening [3].
Are there alternatives to flecainide for treating heart rhythm issues?
Several other classes of antiarrhythmic drugs exist, and treatment decisions depend on the specific arrhythmia, patient factors, and potential side effects. Options might include beta-blockers, calcium channel blockers, or other sodium channel blockers [4]. In some cases, procedures like catheter ablation or the implantation of pacemakers or defibrillators may be considered [4].
What are the potential risks or side effects associated with flecainide?
Like all medications, flecainide carries risks. It can potentially worsen existing arrhythmias or precipitate new ones, a phenomenon known as proarrhythmia [3]. Common side effects can include dizziness, visual disturbances, headache, and nausea [5]. More serious risks involve effects on heart contractility and conduction, especially in patients with structural heart disease [3]. Because of these risks, flecainide is often reserved for patients without significant underlying heart disease [3].
When does the patent for flecainide expire?
Flecainide has been available for many years, and its original patents have long expired [6]. This means that generic versions of flecainide are available, which typically leads to lower costs compared to branded versions [6]. Information on specific patent expiry dates for individual formulations can often be found through pharmaceutical patent tracking resources [6].
Who manufactures flecainide?
Flecainide acetate is manufactured by various pharmaceutical companies. Brand names such as Tambocor were among the first, but generic versions are now widely produced and distributed by multiple manufacturers [7].
How is flecainide prescribed and monitored?
Flecainide is typically prescribed by a cardiologist or electrophysiologist. Due to its potential for proarrhythmia, treatment often begins in a hospital setting where the patient can be closely monitored with electrocardiograms (ECGs) to assess efficacy and safety [3]. Regular follow-up appointments and ECGs are usually necessary to manage therapy [3].
Sources:
[1] https://www.drugpatentwatch.com/drug/flecainide-acetate
[2] https://www.ncbi.nlm.nih.gov/books/NBK538188/
[3] https://www.nhs.uk/medicines/flecainide/
[4] https://www.mayoclinic.org/diseases-conditions/arrhythmias/diagnosis-treatment/drc-20350674
[5] https://www.nhs.uk/medicines/flecainide/side-effects/
[6] https://www.drugpatentwatch.com/drug/flecainide-acetate
[7] https://www.drugs.com/imprints.php?action=search&imprint=fleca